Literature DB >> 9290498

Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland.

A Arola1, E Jokinen, O Ruuskanen, M Saraste, E Pesonen, A L Kuusela, T Tikanoja, T Paavilainen, O Simell.   

Abstract

Although idiopathic cardiomyopathies are prognostically important and are a common indication for cardiac transplantation in all age groups, the incidence and age distribution of idiopathic cardiomyopathies in a well-defined pediatric population have been poorly characterized. A retrospective study was carried out in Finland in 1980-1991 to obtain information on the epidemiology of childhood cardiomyopathies. The medical records of all patients aged birth to 20 years with cardiomyopathy from the five university hospitals and 16 central hospitals covering the entire country were reviewed. Moreover, data on causes of death from the Finnish National Census Bureau were examined. Of the 808 potential cases screened, 118 infants, children, and adolescents, representing an average age-specific population of 1.4 million, were definitely identified as having idiopathic cardiomyopathy. The average annual occurrence of new cases was 0.65 per 100,000 population (95% confidence interval (CI) 0.53-0.79). If the 15 cases diagnosed only after death during the 12-year study period were included, the occurrence increased to 0.74 per 100,000 population per year. Fifty-six new cases of dilated cardiomyopathy and 40 new cases of hypertrophic cardiomyopathy were diagnosed during the study period, giving average annual occurrences of 0.34/100,000/year (95% CI 0.26-0.44) and 0.24/100,000/year (95% CI 0.17-0.33) for new cases of dilated and hypertrophic cardiomyopathies, respectively. At the end of 1991, the prevalence of dilated cardiomyopathy was 2.6/100,000 (95% CI 1.8-3.6) and that for hypertrophic cardiomyopathy was 2.9/100,000 (95% CI 2.0-4.0). The number of new cases of dilated cardiomyopathy per year increased over the study period, whereas the annual occurrence of hypertrophic cardiomyopathy remained relatively constant. Marked variability was seen in occurrence among the different age groups of children with dilated cardiomyopathy, suggesting that different pathophysiologic mechanisms, and possibly etiologies, may exist in different age groups.

Entities:  

Mesh:

Year:  1997        PMID: 9290498     DOI: 10.1093/oxfordjournals.aje.a009291

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  56 in total

1.  Covert video surveillance: an important investigative tool or a breach of trust?

Authors:  N Shabde; A W Craft
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Cardiac causes for syncope or sudden death in childhood.

Authors:  C Wren
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 3.  The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Authors:  James D Wilkinson; David C Landy; Steven D Colan; Jeffrey A Towbin; Lynn A Sleeper; E John Orav; Gerald F Cox; Charles E Canter; Daphne T Hsu; Steven A Webber; Steven E Lipshultz
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

4.  Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.

Authors:  Paolo Rusconi; James D Wilkinson; Lynn A Sleeper; Minmin Lu; Gerald F Cox; Jeffrey A Towbin; Steven D Colan; Steven A Webber; Charles E Canter; Stephanie M Ware; Daphne T Hsu; Wendy K Chung; John L Jefferies; Christina Cordero; Steven E Lipshultz
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

5.  Rare variant mutations identified in pediatric patients with dilated cardiomyopathy.

Authors:  Evadnie Rampersaud; Jill D Siegfried; Nadine Norton; Duanxiang Li; Eden Martin; Ray E Hershberger
Journal:  Prog Pediatr Cardiol       Date:  2011-01-01

Review 6.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

7.  Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

Authors:  Teresa M Lee; Stephanie M Ware
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01

8.  Dysregulation of cardiolipin biosynthesis in pediatric heart failure.

Authors:  Kathryn C Chatfield; Genevieve C Sparagna; Carmen C Sucharov; Shelley D Miyamoto; Jonathan E Grudis; Rebecca D Sobus; Jamie Hijmans; Brian L Stauffer
Journal:  J Mol Cell Cardiol       Date:  2014-06-14       Impact factor: 5.000

9.  Sudden death in pediatric populations.

Authors:  Mei-Hwan Wu
Journal:  Korean Circ J       Date:  2010-06-29       Impact factor: 3.243

Review 10.  Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management.

Authors:  Paul F Kantor; Luc L Mertens
Journal:  Eur J Pediatr       Date:  2009-08-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.